Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases-Reference-Cited by-同舟云学术

Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases

Published:2012-02-14 Issue:1 Volume:403 Page:203-213
ISSN:1618-2642
Container-title:Analytical and Bioanalytical Chemistry
language:en
Short-container-title:Anal Bioanal Chem

Author:

Zhou Lina,Wang Quancai,Yin Peiyuan,Xing Wenbin,Wu Zeming,Chen Shili,Lu Xin,Zhang Yong,Lin Xiaohui,Xu Guowang

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry,Analytical Chemistry

Link

http://link.springer.com/content/pdf/10.1007/s00216-012-5782-4.pdf

Reference50 articles.

1. Feitelson M (1992) Hepatitis-B virus-infection and primary hepatocellular-carcinoma. Clin Microbiol Rev 5:275–301

2. Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM (2007) Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis 27:55–76

3. Farazi PA, DePinho RA (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6:674–687

4. Feitelson MA, Duan LX (1997) Hepatitis B virus× antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Pathol 150:1141–1157

5. Kao JH, Chen PJ, Lai MY, Chen DS (2003) Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers. Gastroenterology 124:327–334

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic phenotyping combined with transcriptomics metadata fortifies the diagnosis of early-stage Hepatocellular carcinoma;Journal of Advanced Research;2024-09

2. Overview of Bovine Mastitis: Application of Metabolomics in Screening Its Predictive and Diagnostic Biomarkers;Animals;2024-08-04

3. Alterations in serum metabolic profiles of early-stage hepatocellular carcinoma patients after radiofrequency ablation therapy;Journal of Pharmaceutical and Biomedical Analysis;2024-06

4. Circulating fatty acids and risk of hepatocellular carcinoma and chronic liver disease mortality in the UK Biobank;Nature Communications;2024-05-02

5. Metabolomic Analysis of Human Cirrhosis and Hepatocellular Carcinoma: A Pilot Study;Digestive Diseases and Sciences;2024-04-23